Peter Welburn

Peter Welburn is currently the Chief Scientific Officer at EPM. Peter has previous experience working at various companies in Australia, Belgium, and the United States in managerial positions. These companies include The Australian Pituitary Foundation Ltd, Eiger Health Consulting Group, LEO Pharma Pty Ltd Australia & New Zealand, and Peplin Inc (Australia). Welburn has a wealth of experience in the field of drug development and marketing, which they have utilised to great effect in their current role.

Peter Welburn's educational career includes obtaining a Doctor of Philosophy (Ph.D.) from the University of Wales, Cardiff, a Master's Degree in Science (Pharmacology) from the University of Sydney, and a Bachelor's Degree in Science (Pharmacology) from The University of Edinburgh.

Peter Welburn reports to Reshef Swisa, Co-Founder & CEO. They work with Rotem Sher - Deputy CEO, Thilo Bayrhoffer - Chief Business Officer, and Zeev Rotstein - President & Head of the Scientific Advisory Board. and Yehudit Natan - Director of R&D reports to Peter Welburn.